Nuwellis, Inc.(NUWE)

Medical - Devices · Eden Prairie, MN

$0.70+0.01 (+1.02%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Price/OCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T22:47:41.202Z.

Stored calculation inputs

Calculation as of: 2026-10-06T22:47:41.202Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 2,557,097
TTM operating cash flow · period ending 2026-06-30: -12,464,000

FMP input reference: 5eb2e86bcba2de742a0c9657979184fcfbe1fcca93de60926014cac74d06dbab

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

NUWE Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

NUWE Competitors' Price/OCF Ratio

NUWE

Nuwellis, Inc.

Current

Market Cap

$2.56M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIAF

bioAffinity Technologies, Inc.

vs NUWE

Market Cap

$2.54M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

UPC

Universe Pharmaceuticals Inc.

vs NUWE

Market Cap

$2.66M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JAGX

Jaguar Health, Inc.

vs NUWE

Market Cap

$2.44M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ISPC

iSpecimen Inc.

vs NUWE

Market Cap

$2.69M

Price/OCF Ratio

N/A

TTM Avg

3804.98

3Y Avg

3804.98

5Y Avg

3804.98

MBRX

Moleculin Biotech, Inc.

vs NUWE

Market Cap

$2.38M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SHPH

Shuttle Pharmaceuticals Holdings, Inc.

vs NUWE

Market Cap

$2.38M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONCO

Onconetix, Inc.

vs NUWE

Market Cap

$2.37M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FBLG

FibroBiologics, Inc. Common Stock

vs NUWE

Market Cap

$2.37M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CELZ

Creative Medical Technology Holdings, Inc.

vs NUWE

Market Cap

$2.32M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
Nuwellis, Inc. (NUWE)	$2.56M	N/A	N/A	N/A	N/A
bioAffinity Technologies, Inc. (BIAF)vs ›	$2.54M	N/A	N/A	N/A	N/A
Universe Pharmaceuticals Inc. (UPC)vs ›	$2.66M	N/A	N/A	N/A	N/A
Jaguar Health, Inc. (JAGX)vs ›	$2.44M	N/A	N/A	N/A	N/A
iSpecimen Inc. (ISPC)vs ›	$2.69M	N/A	3804.98	3804.98	3804.98
Moleculin Biotech, Inc. (MBRX)vs ›	$2.38M	N/A	N/A	N/A	N/A
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs ›	$2.38M	N/A	N/A	N/A	N/A
Onconetix, Inc. (ONCO)vs ›	$2.37M	N/A	N/A	N/A	N/A
FibroBiologics, Inc. Common Stock (FBLG)vs ›	$2.37M	N/A	N/A	N/A	N/A
Creative Medical Technology Holdings, Inc. (CELZ)vs ›	$2.32M	N/A	N/A	N/A	N/A

Operating Cash Flow Valuation

P/OCF Ratio

N/A

P/FCF Ratio

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

NUWE Price/OCF Ratio Metrics

NUWE Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics